AOD-9604 vs 5-Amino-1MQ
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (amino acids 176-191) of human growth hormone, with an added tyrosine residue. Preclinical research has documented its lipolytic activity independent of the broader GH-IGF-1 axis, with selective effects on fat metabolism and no measurable impact on glucose homeostasis or IGF-1 levels. This selectivity makes it a focused research tool for adipocyte biology. 5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that consumes methyl donors and depletes cellular NAD+ pools. By inhibiting NNMT, 5-Amino-1MQ preserves NAD+ availability and shifts adipocyte metabolism toward energy expenditure. Preclinical studies have examined its role in metabolic regulation, fat cell differentiation, and NAD+ salvage pathways.
AOD-9604
5-Amino-1MQ
The Verdict
AOD-9604 and 5-Amino-1MQ both appear in metabolic research but operate through fundamentally different mechanisms. AOD-9604 directly stimulates lipolysis without engaging the broader GH axis, making it useful for studying isolated fat metabolism pathways. 5-Amino-1MQ targets NAD+ availability through NNMT inhibition, addressing metabolic regulation at the cellular energy level. The two are complementary research tools for investigators studying different layers of adipocyte and metabolic biology.
Explore These Products
AOD-9604
A synthetic peptide fragment of human growth hormone (amino acids 177-191) studied for its role in fat metabolism and lipolysis without affecting blood sugar or growth.
View Details →5-Amino-1MQ
A small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied in metabolic research for its potential effects on cellular energy metabolism and fat cell regulation.
View Details →AOD-9604 vs 5-Amino-1MQ — FAQ
Are these compounds chemically related?
Why does AOD-9604 not affect IGF-1?
What is NNMT and why is it relevant?
Can they be combined in research?
References
Primary sources for key clinical and regulatory claims on this page.
- A new anti-obesity compound, AOD9604, reduces body weight in obese Zucker rats by stimulating lipolysis — PubMed / Int J Obes Relat Metab Disord . Primary preclinical source for AOD-9604 lipolytic activity without GH axis engagement.
- Targeting NNMT for metabolic dysfunction — PubMed / Trends Pharmacol Sci . Review of NNMT inhibition as a metabolic research target including 5-Amino-1MQ activity.
Keep Researching
Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.